GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 128 filers reported holding GOSSAMER BIO INC in Q3 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,267 | -30.3% | 14,730 | +5.5% | 0.00% | – |
| Q1 2023 | $17,593 | -49.1% | 13,963 | -12.3% | 0.00% | – |
| Q4 2022 | $34,542 | -80.6% | 15,918 | +7.2% | 0.00% | -100.0% |
| Q3 2022 | $178,000 | +61.8% | 14,846 | +13.5% | 0.00% | – |
| Q2 2022 | $110,000 | -35.3% | 13,080 | -33.2% | 0.00% | – |
| Q1 2022 | $170,000 | -38.4% | 19,571 | -19.6% | 0.00% | -100.0% |
| Q4 2021 | $276,000 | -9.2% | 24,356 | +0.6% | 0.00% | 0.0% |
| Q3 2021 | $304,000 | +25.6% | 24,199 | -18.7% | 0.00% | 0.0% |
| Q2 2021 | $242,000 | +2.1% | 29,771 | +16.3% | 0.00% | 0.0% |
| Q1 2021 | $237,000 | +0.9% | 25,596 | +5.4% | 0.00% | 0.0% |
| Q4 2020 | $235,000 | -1.3% | 24,274 | +26.7% | 0.00% | 0.0% |
| Q3 2020 | $238,000 | -2.9% | 19,165 | +1.7% | 0.00% | 0.0% |
| Q2 2020 | $245,000 | +107.6% | 18,847 | +62.5% | 0.00% | 0.0% |
| Q1 2020 | $118,000 | -62.4% | 11,600 | -42.3% | 0.00% | 0.0% |
| Q4 2019 | $314,000 | – | 20,094 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,320,608 | $41,209,000 | 11.15% |
| Boxer Capital, LLC | 2,562,358 | $31,799,000 | 1.10% |
| Integral Health Asset Management, LLC | 200,000 | $2,482,000 | 0.76% |
| Palo Alto Investors LP | 1,077,200 | $13,368,000 | 0.73% |
| Artal Group S.A. | 2,358,968 | $29,275,000 | 0.71% |
| HHLR ADVISORS, LTD. | 7,420,974 | $92,094,000 | 0.70% |
| MASTERS CAPITAL MANAGEMENT LLC | 700,000 | $8,687,000 | 0.58% |
| Ikarian Capital, LLC | 582,494 | $7,229,000 | 0.52% |
| CLOUGH CAPITAL PARTNERS L P | 459,834 | $5,707,000 | 0.41% |
| Alyeska Investment Group, L.P. | 1,173,301 | $14,561,000 | 0.22% |